CLINICAL_TRIALS
trial_result
· 2022-01-04
Clinical Trial Update: Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia [Phase 2]
Summary
Phase 2 trial evaluating feasibility and effectiveness of inotuzumab ozogamicin in B-cell acute lymphoblastic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Lymphoid Leukemia | Phase 2 | Status: UNKNOWN